SHE:002317 Market Cap

SHE:002317 has a market cap or net worth of 21.12 billion as of June 29, 2026. Its market cap has increased by 85.48% in one year.

Market Cap

21.12B

Enterprise Value

20.00B

Revenue

2.51B

Ranking

n/a

PE Ratio

71.00

Stock Price

24.85

Market Cap Chart

Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 21.12B, an increase of 192.73%. That is a compound annual growth rate of 6.70%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	21.12B	30.93%
Dec 31, 2025	16.13B	56.94%
Dec 31, 2024	10.28B	-24.46%
Dec 29, 2023	13.61B	-37.64%
Dec 30, 2022	21.82B	126.34%
Dec 31, 2021	9.64B	8.90%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Livzon Pharmaceutical Group	23.90B
Zhejiang Huahai Pharmaceutical	21.86B
Jilin Aodong Pharmaceutical Group	21.22B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	20.84B
Shanghai Haoyuan Chemexpress	20.81B
Walvax Biotechnology	20.54B
Tasly Pharmaceutical Group	20.44B
Jiangsu Nhwa Pharmaceutical Co., LTD	19.66B

Market Cap Rankings